Wilson Sonsini Goodrich & Rosati has advised Encoded Therapeutics. Encoded Therapeutics, a clinical-stage biotechnology company, has announced the completion of a $275 million Series F financing...
Encoded Therapeutics Closes $275 Million Series F Financing for Neurological Drug Development
Beren Therapeutics Secures $300 Million in Equity, Debt, and Royalty Financing
Wilson Sonsini Goodrich & Rosati has advised Beren Therapeutics P.B.C. Latham & Watkins has advised Hercules Capital, Inc. Beren Therapeutics P.B.C., a biotechnology company and parent...
Denali Therapeutics Completes $200 Million Public Offering of Common Stock and Pre-Funded Warrants
Wilson Sonsini Goodrich & Rosati has advised Denali Therapeutics. Davis Polk has advised the representatives of the several underwriters. Denali Therapeutics Inc. (Nasdaq: DNLI) has completed...
Treehouse’s $16.6 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Treehouse on the transaction. Treehouse announced $16.6 million in Series A funding. Lead investor Flourish Ventures, Eaton, Veriten, MassMutual Ventures,...
MasterControl’s $150 Million Series A Fundraising
Wilson Sonsini advised MasterControl on the deal while Sidley represented Sixth Street Growth. MasterControl, a leading provider of quality and manufacturing software solutions for the life...
AliveCor’s Series F Financing
Wilson Sonsini advised AliveCor on the deal. AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced its Series F Financing led by GE Healthcare....
Walker & Dunlop’s $85 Million Acquisition of GeoPhy
Wilson Sonsini Goodrich & Rosati advised GeoPhy on the deal while Arnold & Porter advised Walker & Dunlop. Walker & Dunlop announced it has entered into...